| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $3.5M | -28.2% |
| SG&A Expense | $4.2M | -31.3% |
| Operating Income | -$7.7M | +30.5% |
| Net Income | -$7.8M | +31.0% |
| EPS (Basic) | -$2.30 | +75.8% |
| EPS (Diluted) | -$2.30 | +73.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.3M | +44.5% |
| Short-term Investments | $209K | +0.0% |
| Current Assets | $9.4M | +40.2% |
| Total Assets | $9.5M | +40.8% |
| Current Liabilities | $679K | -51.1% |
| Total Liabilities | $705K | -57.0% |
| Stockholders' Equity | $8.8M | +72.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.4M | +9.2% |
| Investing Cash Flow | $1.2M | +0.0% |
| Financing Cash Flow | $11.3M | +87.5% |